# Diagnostic Accuracy of Pleural Effusion Aspergillosis Biomarker Testing

> **NCT02104479** · — · UNKNOWN · sponsor: **Heidelberg University** · enrollment: 200 (estimated)

## Conditions studied

- Invasive Aspergillosis
- Pleural Effusion
- Immunosuppression

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02104479
- **Lead sponsor:** Heidelberg University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-03-31
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2020-04-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02104479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02104479, "Diagnostic Accuracy of Pleural Effusion Aspergillosis Biomarker Testing". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02104479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*